相关实验视频
Updated: Jun 15, 2025

04:39
Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
Published on: March 17, 2023
1.6K
骨髓灰质炎与甲状腺眼病共存的临床特征和治疗效果
Yin Chen1, Shiyin Li2, Jiaxin Chen2
1The People's Hospital of Guangxi Zhuang Autonomous Region (Guangxi Academy of Medical Sciences), No.6 Taoyuan Road, Nanning, Guangxi Zhuang Autonomous Region, China. 1412068898@qq.com.
概括
患有甲状腺眼病 (TED) 的肌痛性肌痛症 (MG) 患者表现出肌腺增生减少和降低乙胆受体抗体标位. 有TED的眼球肌痛性肌痛症 (OMG) 增加了双眼视风险,这给治疗带来了挑战.
科学领域:
- 神经学 神经学
- 内分泌学 在内分泌学.
- 眼科医生 眼科 眼科
背景情况:
- 骨髓灰质炎 (MG) 和甲状腺眼病 (TED) 是可以并存的自身免疫性疾病.
- 了解MG和TED之间的相互作用对于有效的患者管理至关重要.
研究的目的:
- 确定患有同时存在甲状腺眼病 (TED) 的肌痛性肌痛症 (MG) 患者的临床特征和治疗结果.
- 为了比较MG患者和没有甲状腺功能障碍的患者,并分析TED对MG和眼神肌硬化症 (OMG) 的影响.
主要方法:
- 从2012年至2022年期间接受治疗的MG患者的临床数据的回顾性分析.
- 基于甲状腺功能障碍状态,TED的存在和眼部参与 (OMG) 的患者分层.
主要成果:
- 患有甲状腺功能障碍的MG患者与没有甲状腺功能障碍的患者相比,出现更早的发病和更轻微的症状.
- 患有甲状腺功能障碍和TED的患者表现出较低的甲状腺腺激增发病率和乙胆受体抗体标位.
- 患有TED的眼性肌痛性肌痛症 (OMG) 患者患有更高的双眼眼的患病率,这证明很难治疗布罗莫斯提格和葡萄糖皮质激素治疗后.
结论:
- MG和TED的共存与减少的胸腺增生和较低的乙胆受体抗体水平有关.
- 双是TED患者的眼球肌痛性肌痛症 (OMG) 患者的一个重大并发症,呈现出治疗困难.
相关概念视频
Myasthenia Gravis: Overview and Treatment
1.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K
Myasthenia Gravis: Diagnostic Tests
705
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
705
Disorders of the Skeletal Muscle
905
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
905
Chemical Synapses
8.8K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
8.8K
Synthesis and Regulation of Thyroid Hormones
4.3K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
4.3K
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
639
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
639

